Persistent depot of triamcinolone acetonide after a single intravitreal injection

Indian Journal of Ophthalmology

Volumn 53, Issue 1, 2005, Pages 65-66

  Vedantham, Vasumathy ^a   Kolluru, Chandramohan ^a   Ramasamy, Kim ^a  

^a ARAVIND EYE HOSPITAL   (India)

Author keywords

Depot; Intravitreal; Pharmacokinetics; Triamcinolone

Indexed keywords

CORTICOSTEROID; TRIAMCINOLONE ACETONIDE; TRICORT 40;

AGED; ARTICLE; CASE REPORT; CHOROID DISEASE; CHOROIDAL NEOVASCULAR MEMBRANE; CORTICOSTEROID THERAPY; DIABETIC RETINOPATHY; DRUG ACCUMULATION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LOW LEVEL LASER THERAPY; MALE; OPHTHALMOSCOPY; PHARMACOKINETICS; PROGNOSIS; VISUAL ACUITY; VISUAL DISORDER;

EID: 17144412522     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: 10.4103/0301-4738.15291     Document Type: Article

References (6)

1. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-86.
2. Scholes GN, O'Brien WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol 1985;103:1567-69.
3. Schindler RH, Chandler D, Thresher R, Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 1982;93:415-17.
4. Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 2003;121:729-30.
5. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-68.
6. Gillies HC, Simpson JM, Luo W, Penfold P, Hunyor ABL, Chua W, Mitchell P, Billson F. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration. One-year results. Arch Ophthalmol 2003;121:667-73.